Abstract
Double-stranded RNAs (dsRNA) possess immense potential for biomedical applications. However, their therapeutic utility is limited by low stability and poor cellular uptake. Different strategies have been explored to enhance the stability of dsRNA, including the incorporation of modified nucleotides, and the use of diverse carrier systems. Nevertheless, these have not resulted in a broadly applicable approach thereby preventing the wide-spread application of dsRNA for therapeutic purposes. Herein, we report the design of dimeric stapled peptides based on the RNA-binding protein TAV2b. These dimers are obtained via disulfide formation and mimic the natural TAV2b assembly. They bind and stabilize dsRNA in the presence of serum, protecting it from degradation. In addition, peptide binding also promotes cellular uptake of dsRNA. Importantly, peptide dimers monomerize under reducing conditions which results in a loss of RNA binding. These findings highlight the potential of peptide-based RNA binders for the stabilization and protection of dsRNA, representing an appealing strategy towards the environment-triggered release of RNA. This can broaden the applicability of dsRNA, such as short interfering RNAs (siRNA), for therapeutic applications.
Original language | English |
---|---|
Article number | e202308028 |
Number of pages | 7 |
Journal | Angewandte Chemie. International Edition |
Volume | 62 |
Issue number | 41 |
Early online date | 21 Aug 2023 |
DOIs | |
Publication status | Published - 9 Oct 2023 |
Bibliographical note
Funding Information:This work was supported by the European Research Council (ERC starting grant number 678623, and ERC proof of concept grant 101112973) and Instruct‐ERIC (PID 26489). E.C.C. received funding from the Radboudumc. We thank Dr. Alexander Fish and Dr. Patrick Celie (NKI) for technical ITC support.
Publisher Copyright:
© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Funding
This work was supported by the European Research Council (ERC starting grant number 678623, and ERC proof of concept grant 101112973) and Instruct‐ERIC (PID 26489). E.C.C. received funding from the Radboudumc. We thank Dr. Alexander Fish and Dr. Patrick Celie (NKI) for technical ITC support.
Funders | Funder number |
---|---|
Horizon 2020 Framework Programme | 678623 |
European Research Council | PID 26489, 101112973 |
Keywords
- Reversible Dimerization
- RNA Delivery
- RNA Stabilization
- RNA/Peptide Complex
- TAV2b